[Pathological gambling induced by dopamine agonists]
- PMID: 21809260
- DOI: 10.1055/s-0031-1281580
[Pathological gambling induced by dopamine agonists]
Abstract
Problems with impulse control and pathological gambling are known as possible side effects of dopaminergic therapy in patients with Parkinson's disease. We report 2 cases of pathological gambling induced by dopamine agonists in patients without Parkinson's disease. The first patient, a 46-year-old man, was treated with ropinirole for restless legs syndrome and had lost huge amounts of money in the context of internet-based poker game. Another 46-year-old male patient developed pathological gambling under treatment with cabergoline administered for prolactinoma. The two cases implicate pathological gambling as a possible consequence of dopaminergic treatment and support the increasing evidence regarding pathological gambling as an adverse drug reaction of dopaminergic treatment, also in patients who do not suffer from Parkinson's disease.
© Georg Thieme Verlag KG Stuttgart · New York.
Similar articles
-
Pathological gambling plus hypersexuality in restless legs syndrome: a new case.Neurol Sci. 2011 Aug;32(4):707-9. doi: 10.1007/s10072-011-0605-5. Epub 2011 May 13. Neurol Sci. 2011. PMID: 21567182
-
Pathological gambling associated with cabergoline therapy in a patient with a pituitary prolactinoma.J Neuropsychiatry Clin Neurosci. 2007 Fall;19(4):473-4. doi: 10.1176/jnp.2007.19.4.473. J Neuropsychiatry Clin Neurosci. 2007. PMID: 18070857 No abstract available.
-
[Ropinirole in the treatment of restless legs].Ugeskr Laeger. 2005 Jun 6;167(23):2541; author reply 2541-2. Ugeskr Laeger. 2005. PMID: 16008015 Danish. No abstract available.
-
Pituitary apoplexy associated with cabergoline therapy.J Clin Neurosci. 2013 Dec;20(12):1637-43. doi: 10.1016/j.jocn.2013.02.027. Epub 2013 Oct 7. J Clin Neurosci. 2013. PMID: 24113159 Review.
-
Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease.Physiol Behav. 2011 Jul 25;104(1):168-72. doi: 10.1016/j.physbeh.2011.04.055. Epub 2011 May 5. Physiol Behav. 2011. PMID: 21557955 Review.
Cited by
-
Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study.J Endocrinol Invest. 2021 Aug;44(8):1699-1706. doi: 10.1007/s40618-020-01478-0. Epub 2020 Dec 12. J Endocrinol Invest. 2021. PMID: 33314003 Free PMC article.
-
Neuropsychiatric and metabolic aspects of dopaminergic therapy: perspectives from an endocrinologist and a psychiatrist.Endocr Connect. 2018 Feb;7(2):R88-R94. doi: 10.1530/EC-18-0030. Epub 2018 Jan 29. Endocr Connect. 2018. PMID: 29378769 Free PMC article. Review.
-
Increased Risk for New-Onset Psychiatric Adverse Events in Patients With Newly Diagnosed Primary Restless Legs Syndrome Who Initiate Treatment With Dopamine Agonists: A Large-Scale Retrospective Claims Matched-Cohort Analysis.J Clin Sleep Med. 2019 Sep 15;15(9):1225-1232. doi: 10.5664/jcsm.7908. J Clin Sleep Med. 2019. PMID: 31538593 Free PMC article.
-
Impulse control disorders in hyperprolactinemic patients on dopamine agonist therapy.Rev Endocr Metab Disord. 2022 Oct;23(5):1089-1099. doi: 10.1007/s11154-022-09753-6. Epub 2022 Sep 20. Rev Endocr Metab Disord. 2022. PMID: 36125673 Review.
-
Drugs-Induced Pathological Gambling: An Analysis of Italian Spontaneous Reporting System.J Gambl Stud. 2020 Mar;36(1):85-96. doi: 10.1007/s10899-019-09828-1. J Gambl Stud. 2020. PMID: 30671764 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical